Effects of Weight Loss Surgery on Bone Health in Adolescents
Bone Metabolism in Adolescents Undergoing Bariatric Surgery
1 other identifier
observational
240
1 country
1
Brief Summary
The purpose of this study is to examine the impact of weight-loss surgery (Roux-en-Y gastric bypass or Vertical Sleeve Gastrectomy) on bone outcomes in girls and boys ages 13-21. This study will also examine a group of overweight boys and girls who are not scheduled or planned for surgery for comparison of these outcomes. Obese adults who undergo weight-loss surgery are at risk for bone loss and decreased bone strength. The investigators do not know the effects of such surgery on bone in teenagers and young adults. The purpose of this study is to find out how different types of weight loss surgery affect bone density and strength in teenagers and young adults and compare these results to obese teenagers and young adults who are not undergoing weight-loss surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 21, 2015
CompletedFirst Posted
Study publicly available on registry
September 23, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
September 25, 2025
September 1, 2025
11.6 years
September 21, 2015
September 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Baseline to 24 months change in total and trabecular volumetric BMD (vBMD) (distal radius and tibia)
2 years
Secondary Outcomes (2)
Baseline to 24 month change in bone turnover markers (P1NP and CTX)
2 years
Baseline to 24 month change in estimated strength measures (FEA of distal radius and tibia)
2 years
Study Arms (3)
Roux-en-Y Gastric Bypass
Males and females aged 13-25 undergoing Roux-en-Y gastric bypass (RYGB) surgery
Vertical Sleeve Gastrectomy
Males and females aged 13-25 undergoing vertical sleeve gastrectomy (VSG) surgery
Non-surgical Obese Controls
Males and females aged 13-25 who are obese and not undergoing weight loss surgery
Interventions
Determination of the kind of surgery will be made by the participant's providers and not by study staff
Determination of the kind of surgery will be made by the participant's providers and not by study staff
Eligibility Criteria
Adolescents and young adults 13-25 years old with obesity undergoing RYGB or VSG and non-surgical controls.
You may qualify if:
- Adolescents with morbid obesity 13-25yo undergoing RYGB (n=36) or VSG (n=36), or being followed without surgical intervention (usual care) (n=48).
- Eligibility criteria for weight loss surgery used at the Weight Center include BMI\>40 or BMI\>35kg/m2 with major comorbidities. A BMI\>35 in adolescents reflects a BMI\>99th percentile. In order to be considered appropriate surgical candidates, children must have a bone age of ≥14y (F) or ≥16y (M), and ≥1 co-morbidity of obesity. They must have demonstrated efforts at non-surgical weight loss, and consistent compliance with appointments and recommendations. Patients must demonstrate sufficient maturity, psychological stability and cognitive capacity to recognize the significance of the procedure and implement required post-operative behavioral changes.
You may not qualify if:
- Current pregnancy and breast feeding
- Medications other than calcium or vitamin D that affect bone, such as glucocorticoids, phenytoin, phenobarbitone (washout of 3 months prior to enrollment if discontinuation is medically permissible)
- Use of antipsychotic medications that cause weight gain if treated for \<6 mos, or if dosage is not stable for \>2 mos
- Untreated thyroid dysfunction or on stable dose for \<3 mos
- HbA1C\>8% (to avoid deleterious effects on bone from uncontrolled T2DM)
- Smoking \>10 cigarettes/day; substance abuse per Diagnostic and Statistical Manual (DSM) V
- Metal implants, intracranial surgical clips or pacemakers
- Weight \>450 lbs due to limits for MRI and CT.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Related Publications (8)
Tuli S, Lopez Lopez AP, Nimmala S, Pedreira CC, Singhal V, Bredella MA, Misra M. Two-Year Study on the Impact of Sleeve Gastrectomy on Depressive and Anxiety Symptoms in Adolescents and Young Adults with Moderate to Severe Obesity. Obes Surg. 2024 Feb;34(2):568-575. doi: 10.1007/s11695-023-07025-z. Epub 2024 Jan 4.
PMID: 38177554DERIVEDMitchell DM, Singhal V, Nimmala S, Lauze M, Bouxsein ML, Misra M, Bredella MA. Risk of wrist fracture, estimated by the load-to-strength ratio, declines following sleeve gastrectomy in adolescents and young adults. Osteoporos Int. 2024 Feb;35(2):285-291. doi: 10.1007/s00198-023-06941-1. Epub 2023 Oct 21.
PMID: 37864596DERIVEDKaur S, Nimmala S, Singhal V, Mitchell DM, Pedreira CC, Lauze M, Lee H, Stanford FC, Bouxsein ML, Bredella MA, Misra M. Bone changes post-sleeve gastrectomy in relation to body mass and hormonal changes. Eur J Endocrinol. 2023 Sep 1;189(3):346-354. doi: 10.1093/ejendo/lvad121.
PMID: 37633255DERIVEDKaur S, Bredella MA, Misra M, Singhal V. Trajectory of Gonadal Hormones in Adolescent Males up to 2 Years After Sleeve Gastrectomy. Obes Surg. 2023 Oct;33(10):3323-3326. doi: 10.1007/s11695-023-06759-0. Epub 2023 Aug 10.
PMID: 37561269DERIVEDLopez Lopez AP, Tuli S, Lauze M, Becetti I, Pedreira CC, Huber FA, Omeroglu E, Singhal V, Misra M, Bredella MA. Changes in Hepatic Fat Content by CT 1 Year After Sleeve Gastrectomy in Adolescents and Young Adults With Obesity. J Clin Endocrinol Metab. 2023 Nov 17;108(12):e1489-e1495. doi: 10.1210/clinem/dgad390.
PMID: 37403207DERIVEDHuber FA, Singhal V, Tuli S, Becetti I, Lopez Lopez AP, Bouxsein ML, Misra M, Bredella MA. Two-year Skeletal Effects of Sleeve Gastrectomy in Adolescents with Obesity Assessed with Quantitative CT and MR Spectroscopy. Radiology. 2023 Jun;307(5):e223256. doi: 10.1148/radiol.223256.
PMID: 37310246DERIVEDMitchell DM, Singhal V, Animashaun A, Bose A, Carmine B, Stanford FC, Inge TH, Kelsey MM, Lee H, Bouxsein ML, Yu EW, Bredella MA, Misra M. Skeletal Effects of Sleeve Gastrectomy in Adolescents and Young Adults: A 2-Year Longitudinal Study. J Clin Endocrinol Metab. 2023 Mar 10;108(4):847-857. doi: 10.1210/clinem/dgac634.
PMID: 36314507DERIVEDNimmala S, Kaur S, Singhal V, Mitchell DM, Stanford FC, Bouxsein ML, Lauze M, Huynh C, Pedreira CC, Lee H, Bredella MA, Misra M. Changes in Sex Steroids and Enteric Peptides After Sleeve Gastrectomy in Youth in Relation to Changes in Bone Parameters. J Clin Endocrinol Metab. 2022 Aug 18;107(9):e3747-e3758. doi: 10.1210/clinem/dgac361.
PMID: 35689793DERIVED
Biospecimen
Blood samples, fecal samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Madhu Misra, MD, MPH
Massachusetts General Hospital
- PRINCIPAL INVESTIGATOR
Miriam Bredella, MD
Massachusetts General Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pediatrics
Study Record Dates
First Submitted
September 21, 2015
First Posted
September 23, 2015
Study Start
June 1, 2015
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
March 31, 2027
Last Updated
September 25, 2025
Record last verified: 2025-09